Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Y. Chikhareva
Observed names:
Y. E. Chihareva,
Y. E. Chikhareva,
Ya. E. Chikhareva,
Yа. E. Chikhareva,
Я. Е. Чихарева
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
Observed institutions:
Sechenov University,
Russian Cancer Research Center NN Blokhin,
Tver State Medical University,
Ministry of Health of the Russian Federation
ORCID:
0009-0009-6649-9856
Observed ORCID:
0009-0009-6649-9856
OpenAlex ID:
A5033555960
P-333 Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer
2023
·
Y. Chikhareva
, M. Fedyanin
, et al.
·
Annals of Oncology
·
4
PDF
Systemic therapy for metastatic pancreatic cancer
2023
·
Y. E. Chikhareva
, M. Yu. Fedyanin
, et al.
·
Malignant tumours
·
2
PDF
455P Reinduction of mFOLFIRINOX in the treatment of pancreatic cancer
2026
·
A.Y. Kashcheeva
, A.A. Tryakin
, et al.
·
Annals of Oncology
PDF
Comparison of efficacy and tolerability of gemcitabine and gemcitabine plus nab-paclitaxel in 2nd line therapy for pancreatic cancer. Experience of one center
2026
·
Y. E. Chikhareva
, D. M. Kantieva
, et al.
·
Surgery and Oncology
PDF
Efficacy of mFOLFIRINOX reinduction in locally advanced unresectable and metastatic pancreatic cancer in real clinical practice
2026
·
A. Yu. Kashcheeva
, Ya. E. Chikhareva
, et al.
·
Medical alphabet
PDF
Эффективность реиндукции mFOLFIRINOX при местно-распространенном нерезектабельном и метастатическом раке поджелудочной железы в реальной клинической практике
2026
·
А. Ю. Кащеева
, Я. Е. Чихарева
, et al.
·
Medical alphabet
PDF
Combined treatment for locally advanced BRCA1-associated pancreatic cancer: a case report
2025
·
A. Yu. Kashcheeva
, A. N. Polyakov
, et al.
·
Medical alphabet
Expression characteristics of tumors as prognostic and predictive markers for resectable and locally advanced colorectal cancer
2024
·
G. G. Makiev
, M. Yu. Fedyanin
, et al.
·
Russian Journal of Biotherapy
Efficacy and safety of different chemotherapy regimens in patients with disseminated pancreatic cancer over 65 years old
2024
·
M. Sh. Manukyan
, Ya. E. Chikhareva
, et al.
·
Surgery and Oncology
377P Prognostic model and treatment outcomes in elderly patients with metastatic pancreatic cancer
2024
·
M. Mariam
, I. Bazin
, et al.
·
Annals of Oncology
PDF
Экспрессионные характеристики опухоли как прогностические и предиктивные маркеры резектабельного и местно-распространенного колоректального рака
2024
·
Г. Г. Макиев
, М. Ю. Федянин
, et al.
·
Russian Journal of Biotherapy
170P KRAS status in patients with pancreatic ductal adenocarcinoma: A single-center study from 2020 to 2023
2023
·
M. Manukyan
, E. Ignatova
, et al.
·
ESMO Open
PDF
P-336 Neoadjuvant chemotherapy of the mFOLFIRINOX in the treatment of resectable pancreatic cancer
2023
·
D. Kantieva
, I. Bazin
, et al.
·
Annals of Oncology
PDF
P-186 Efficacy of the combined chemotherapy regimens in elderly patients with advanced pancreatic cancer
2023
·
M. Manukyan
, I. Bazin
, et al.
·
Annals of Oncology
PDF
A Paradigm Shift in the Treatment of Patients With Resectable Pancreatic Cancer
2020
·
E. Yu. Antonova
, I. S. Bazin
, et al.
·
Siberian Journal of Oncology
PDF
Surgical and combined treatment for patients with cholangiocarcinoma: the experience of FSBI
2019
·
A. Polyakov
, Y. Patutko
, et al.
·
Annals of Oncology
Место Химиотерапии В Лечении Локализованного Рака Поджелудочной Железы
2016
·
I. Bazin
, И. А. Покатаев
, et al.
·
Злокачественные опухоли
Show more works
View as search
Works count:
18
Citation count:
6
H-index:
2
I10-index:
Year
Topic
Type